These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29474640)

  • 21. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier.
    On NH; Miller DW
    Curr Pharm Des; 2014; 20(10):1499-509. PubMed ID: 23789953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
    Black KL; Ningaraj NS
    Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
    Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
    Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
    Zhang F; Xu CL; Liu CM
    Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
    Wang Z; Sun H; Yakisich JS
    Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.
    Greig NH; Soncrant TT; Shetty HU; Momma S; Smith QR; Rapoport SI
    Cancer Chemother Pharmacol; 1990; 26(4):263-8. PubMed ID: 2369790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
    Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C
    Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The blood-brain barrier disruption controversy: does it hold water?
    Ruffer JE; Glatstein E
    Cancer J Sci Am; 1998; 4(2):84-5. PubMed ID: 9532409
    [No Abstract]   [Full Text] [Related]  

  • 32. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
    Duan M; Xing Y; Guo J; Chen H; Zhang R
    Pharm Biol; 2016 Dec; 54(12):3009-3018. PubMed ID: 27431008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood brain barrier: a challenge for effectual therapy of brain tumors.
    Bhowmik A; Khan R; Ghosh MK
    Biomed Res Int; 2015; 2015():320941. PubMed ID: 25866775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
    Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
    Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstacles to Brain Tumor Therapy: Key ABC Transporters.
    Wijaya J; Fukuda Y; Schuetz JD
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
    Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
    J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting anticancer drugs to the brain: II. Physiological pharmacokinetic model of oxantrazole following intraarterial administration to rat glioma-2 (RG-2) bearing rats.
    Gallo JM; Varkonyi P; Hassan EE; Groothius DR
    J Pharmacokinet Biopharm; 1993 Oct; 21(5):575-92. PubMed ID: 8145132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
    Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
    Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics and the blood-brain barrier.
    Blasberg RG
    Natl Cancer Inst Monogr; 1977 Dec; 46():19-27. PubMed ID: 349396
    [No Abstract]   [Full Text] [Related]  

  • 40. Relation between polyporphyrin distribution and blood brain barrier changes in the rat glioma model.
    Ji Y; Walstad DL; Brown JT; Powers SK
    Lasers Surg Med; 1992; 12(2):174-9. PubMed ID: 1533436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.